CXCL8 and Bartsocas-Papas syndrome 1: In addition, PRP treatment significantly increased urinary IL-2 and IL-8 biomarkers in these IC/BPS patients, suggesting that the effect of PRP through modulating bladder inflammation responses [224,225].